BRAF and hematocrit: Similarly, patients with wild-type BRAF PTCs without underlying HT had higher rates of central (17.3% vs. 14.1%; p < 0.001) and lateral LNM (10.7% vs. 8.2%; p < 0.001) when compared to patients with HT.